US 7,320,869 B2 | ||
Antibodies to Chemokine Alpha-5 | ||
Ying-Fei Wei, Berkeley, Calif. (US); Yi Li, Sunnyvale, Calif. (US); Jian Ni, Germantown, Md. (US); Craig A. Rosen, Laytonsville, Md. (US); and Steven M. Ruben, Brookeville, Md. (US) | ||
Assigned to Human Genome Sciences, Inc., Rockville, Md. (US) | ||
Filed on Sep. 13, 2005, as Appl. No. 11/224,076. | ||
Application 11/224076 is a division of application No. 10/114482, filed on Apr. 03, 2002, granted, now 7,060,261. | ||
Application 10/114482 is a division of application No. 09/195106, filed on Nov. 18, 1998, granted, now 6,395,514, filed on May 28, 2002. | ||
Claims priority of provisional application 60/066369, filed on Nov. 21, 1997. | ||
Prior Publication US 2006/0008882 A1, Jan. 12, 2006 | ||
Int. Cl. G01N 33/53 (2006.01); C12N 5/12 (2006.01); C07K 16/24 (2006.01) |
U.S. Cl. 435—7.1 [435/326; 530/387.1; 530/387.9; 530/388.1; 530/387.3] | 28 Claims |
1. An isolated antibody or fragment thereof that specifically binds to a protein selected from the group consisting of:
(a) a protein whose amino acid sequence consists of amino acid residues 1 to 254 of SEQ ID NO:2;
(b) a protein whose amino acid sequence consists of amino acid residues 28 to 254 of SEQ ID NO:2;
(c) a protein whose amino acid sequence consists of amino acid residues 28 to 205 of SEQ ID NO:2;
(d) a protein whose amino acid sequence consists of a portion of SEQ ID NO:2, wherein said portion is at least 30 contiguous
amino acid residues in length; and
(e) a protein whose amino acid sequence consists of a portion of SEQ ID NO:2, wherein said portion is at least 50 contiguous
amino acid residues in length.
|